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Abstract
Background: The use of alternative modeling techniques for predicting patient survival is complicated by the fact that some
alternative techniques cannot readily deal with censoring, which is essential for analyzing survival data. In the current study,
we aimed to demonstrate that pseudo values enable statistically appropriate analyses of survival outcomes when used in
seven alternative modeling techniques.
Methods: In this case study, we analyzed survival of 1282 Dutch patients with newly diagnosed Head and Neck Squamous
Cell Carcinoma (HNSCC) with conventional Kaplan-Meier and Cox regression analysis. We subsequently calculated pseudo
values to reflect the individual survival patterns. We used these pseudo values to compare recursive partitioning (RPART),
neural nets (NNET), logistic regression (LR) general linear models (GLM) and three variants of support vector machines (SVM)
with respect to dichotomous 60-month survival, and continuous pseudo values at 60 months or estimated survival time. We
used the area under the ROC curve (AUC) and the root of the mean squared error (RMSE) to compare the performance of
these models using bootstrap validation.
Results: Of a total of 1282 patients, 986 patients died during a median follow-up of 66 months (60-month survival: 52%
[95% CI: 50%255%]). The LR model had the highest optimism corrected AUC (0.791) to predict 60-month survival, followed
by the SVM model with a linear kernel (AUC 0.787). The GLM model had the smallest optimism corrected RMSE when
continuous pseudo values were considered for 60-month survival or the estimated survival time followed by SVM models
with a linear kernel. The estimated importance of predictors varied substantially by the specific aspect of survival studied
and modeling technique used.
Conclusions: The use of pseudo values makes it readily possible to apply alternative modeling techniques to survival
problems, to compare their performance and to search further for promising alternative modeling techniques to analyze
survival time.
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Introduction
Predicting the survival probability of patients is important for
various purposes in biomedical research, such as patient counsel-
ling, medical decision making, and benchmarking. The conven-
tional analysis of survival problems mainly relies on Kaplan-Meier
analysis and Cox regression modeling to predict the survival
probability in relation to predictor variables [1,2].
Alternative modeling techniques are available, such as support
vector machines and artificial neural networks [3–5], which might
possibly provide better predictions. For example, feed forward
neural networks were already used in 1998 for the analysis of
censored survival data [6]. In 2007, applications of random
survival forests were described [7]. In 2009, prognostic indexes
were compared using data mining techniques and Cox regression
analysis in breast cancer data [8].
In 2000, Schwarzer and Vach [9] reviewed the use of artificial
neural networks in medical research and found several problems.
A major problem was that some of the alternative techniques did
not deal adequately with censoring, which is essential for analyzing
survival data. The conventional analysis of survival outcomes
requires two variables: the status of the patient (e.g. dead or alive)
and the time point at which this status is measured. In 2008, Klein
et al. [10,11] proposed to predict the survival at particular time
points using pseudo values, which combine the variables status and
time point in one outcome variable. The use of these pseudo
values in generalized estimating equation modeling (GEE) using a
log-minus-log link function leads to statistically appropriate
analyses, which are in line with the results of Cox regression
modeling.
In the current study, we aimed to study the use of pseudo values
for analyses of survival outcomes with other modeling techniques,
including support vector machines (SVM), neural networks
(NNET), general linear models (GLM), recursive partitioning
(RPART) and logistic regression (LR). To compare the perfor-
mance, we applied these techniques and conventional regression
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analysis in the prediction of survival of 1282 Dutch patients with
Head and Neck Squamous Cell Carcinoma (HNSCC), using
predictors as described in earlier studies [12–14]. The survival of
this particular population of newly diagnosed patients with
HNSCC has already been studied by applying conventional
Kaplan-Meier analysis, Cox regression and random survival
forests (RSF) to 60-month survival and overall survival [15–17].
Methods
Patients and Data
We considered a cohort of 1371 patients with Head and Neck
Squamous Cell Carcinoma (HNSCC) of the oral cavity, pharynx
or larynx, diagnosed at Leiden University Medical Centre. The
data were obtained from files used in an earlier study [16]. The
same data had been used before to derive a prediction model
based on the Cox regression modeling technique [15]. Predictors
in this model included Tumor location, Age at diagnosis, Gender,
T-N-M classification (T= the extent of the primary tumor, N= the
absence or presence and extent of regional lymph node metastasis,
M= the absence or presence of distant metastasis) and Prior
malignancies. In 2010, Datema et al. [16,17] published an
updated model including comorbidity according to the Adult
Comorbidity Evaluation, based on a 27-item comorbidity index
(ACE27) [18]. In our study, we excluded patients for whom
comorbidity was unknown, resulting in a total of 1282 patients.
Outcome Variables
We defined three outcome variables related to patient survival:
a) The 60-month survival (dichotomous, dead or alive, ignoring
censoring before 60 months)
b) The pseudo values at 60 months (continuous)
c) The estimated survival time (continuous)
We focused on 60-month survival, since this is a common time
point in cancer research. We subsequently calculated pseudo
values for the time points 12, 24,…, 288, and 300 months to reflect
the individual survival patterns of patients using the R-package
‘‘Pseudo’’. The pseudo values form a new set of observations to
allow for analysis as if we had time-to-event data without censoring
[10,11].
The estimated survival time was calculated as the sum of the
pseudo values at these time points, because this sum reflects the
area under the survival curve and can be interpreted as the mean
survival time. The choice for a time interval of 12 months was
motivated by the wish to have around 25 time intervals per subject
for sufficient accuracy in estimating the survival time. File S1
(appendix 1) gives a more detailed description of the calculation
and interpretation of the pseudo values and the estimated survival
time. For univariate analysis of 60-month survival and overall
survival we used Kaplan-Meier analysis and Cox regression
analysis.
Modeling Techniques
We considered the following modeling techniques: support
vector machines (SVM), neural networks (NNET), recursive
partitioning (RPART), general linear models (GLM) and logistic
regression (LR), with their implementations as available in the
software package R, version 2.14.1 [19]. The parameters of the
various modelling techniques are presented in Table 1.
File S2 (appendix 2) presents a more detailed description of the
various modeling techniques and their parameters, based on
previous literature [20–27].
Tuning of the Modeling Techniques
Before applying a modeling technique, we tuned that technique
by varying the parameters to create an optimal model fit. The
optimal parameter setting was based on the smallest prediction
error after 10-fold cross validation. The modeling technique SVM
was tuned using a simultaneous grid search for the parameters cost
and gamma when a radial or linear kernel was used and for the
parameters cost, gamma and degree when a polynomial kernel
was used. The modeling technique NNET was tuned using a
simultaneous grid search for the parameter size, and the modeling
technique RPART was tuned by varying the cp-value.
Validation and Performance of the Modeling Techniques
For all models, internal validation was done by bootstrap
resampling (200 bootstrap samples). From the original data set a
bootstrap sample was drawn (randomly and with replacement).
Then the modeling technique was tuned to create an optimal
model fit for this bootstrap sample. With the optimal setting
resulting from the tuning, we applied the modeling technique to
the bootstrap sample and calculated the performance of the
resulting model (bootstrap performance). We then applied the
model to the original data base and calculated the performance
(validated performance). This process was repeated 200 times. The
200 results were averaged to produce a single estimation of the
bootstrap performance and the validated performance [28]. The
difference of the mean bootstrap performance and the mean
validated performance indicated the optimism of a model. The
optimism corrected performance was calculated by subtracting the
optimism from the apparent performance estimate, i.e. when the
model was optimized and assessed for its performance on the
original data set. With respect to dichotomous 60-month survival,
the performance measure was the area under the ROC-curve
(AUC). With respect to continuous pseudo values at 60 months
and estimated survival time, the performance of the models was
calculated using the root of the mean squared error (RSME).
Table 1. Parameters required for the modeling techniques.
Modeling technique Parameters
NNET size and decay
RPART cp-value
SVM LINEAR cost and gamma
SVM POLYNOMIAL cost, gamma and degree
SVM RADIAL cost and gamma
doi:10.1371/journal.pone.0100234.t001
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Variable Importance
We calculated the relative importance of each of the eight
predictor variables in a model by calculating the difference
between the validated performance of the full model with all eight
predictor variables and the validated performance of the model
with seven predictor variables, leaving out each predictor variable
in turn.
Figure 1. Survival pattern 1282 patients with newly diagnosed HNSCC.
doi:10.1371/journal.pone.0100234.g001
Figure 2. Censoring pattern 1282 patients with newly diagnosed HNSCC.
doi:10.1371/journal.pone.0100234.g002
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Ethics Statement
Patient data were used that had been collected prospectively
and anonymously between 1981–1998. According to Dutch
regulations, neither medical nor ethical approval was required to
conduct the study, as no interventions were initiated and the study
had no influence on medical care nor on decision making. The
data was anonymised. The study was not supported financially in
any way.
Results
Patients and Data
Of the 1371 patients included originally, we dropped 89
patients for whom the comorbidity was unknown. As a result, we
included 1282 patients in our analysis. Of these, 986 patients died
during a median follow-up of 66 months (60-month survival: 52%
[95% CI: 50%255%], Figure 1). The censoring pattern of the
patients (censoring rate before 60 months: 4%) is presented in
Figure 2.
Table 2 shows the overall number of events and the survival
probabilities for each category of the predictor variables with
respect to the Kaplan-Meier estimated 60-month survival. Several
characteristics were associated with a poor 60-month survival:
Tumor location in the Hypopharynx, Oral cavity and Orophar-
ynx (60-month survival 0.33, 0.36 and 0.37 respectively), cancer
stages T3, T4, and N3 (60-month survival 0.38, 0.27, 0.11
respectively), higher age (Age .=70, 60-month survival 0.40) and
severe comorbidity (Grade 3 of ACE27, 60-month survival 0.25).
Model Performance and Optimism
We evaluated the performance of the various models with
respect to the three survival related outcome variables.
For the outcome ‘dead or alive at 60 months’, the LR model
had the highest optimism corrected AUC (0.791, Table 3) followed
by the SVM model with linear kernel (AUC 0.787, Table 3). The
NNET model performed slightly poorer (AUC 0.785, Table 3).
The RPART model had the lowest AUC (0.725, Table 3).
Considering the outcome ‘pseudo values at 60 months’, the
GLM model had the highest optimism corrected RMSE (0.436,
Table 4). The SVM model with polynomial kernel and the NNET
model performed poorly (RMSE 0.482 and 0.486 respectively,
Table 4).
Analyzing the outcome ‘estimated survival time’, the GLM
model had the lowest optimism corrected RMSE (77.7, Table 5),
followed by the SVM model with a linear kernel (79.2, Table 5).
The NNET model had the worst RMSE (83.7, Table 5).
The regression based models (LR and GLM) had relatively
small optimism. This small optimism was also noted for the SVM
models with a linear kernel. The bootstrap-estimated optimism
was substantial for NNET and the more complex SVM models
with polynomial and radial kernels (Table 3 to Table 5).
Variable Importance
For each model and for each outcome we calculated the
variable importance (Figure 3). We chose the parameter settings of
the modeling techniques based on the highest frequency (mode)
resulting from the bootstrap procedure (Table 6).
Figure 3 shows the variable importance for each model and for
each outcome with these parameter settings.
Overall, the variables Tumor location, T-class and N-class were
the most important predictor variables for predicting the
dichotomous and continuous 60-months survival (Figure 3).
Survival probability was considerably lower for patients with
cancer stages T4 and N3 (File S3 (appendix 3), Table 7, Table 8).
Table 3. Performance of models for the outcome ‘dead or alive at 60 months’.
Dead or alive at 60 months
Modeling technique AUC bootstrap AUC validated AUC-apparent Optimism Optimism-corrected-AUC
LR 0.809 0.797 0.803 0.012 0.791
NNET 0.880 0.810 0.855 0.070 0.785
RPART 0.769 0.741 0.753 0.028 0.725
SVM LINEAR 0.807 0.794 0.800 0.013 0.787
SVM POLYNOMIAL 0.861 0.811 0.821 0.050 0.771
SVM RADIAL 0.872 0.813 0.825 0.059 0.766
doi:10.1371/journal.pone.0100234.t003
Table 4. Performance of models for the outcome ‘pseudo values at 60 months’.
Pseudo values at 60 months
Modeling technique RMSE bootstrap RMSE validated RMSE-apparent Optimism Optimism-corrected-RMSE
GLM 0.427 0.433 0.430 0.006 0.436
NNET 0.388 0.457 0.417 0.069 0.486
RPART 0.430 0.448 0.448 0.018 0.466
SVM LINEAR 0.461 0.470 0.460 0.009 0.469
SVM POLYNOMIAL 0.409 0.445 0.446 0.036 0.482
SVM RADIAL 0.428 0.446 0.442 0.018 0.460
doi:10.1371/journal.pone.0100234.t004
Prediction of Survival with Pseudo Values
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For the estimated survival time, age at diagnosis was the most
important predictor variable (Figure 3). Cancer stages T1 and N0
indicated a relatively good survival probability (File S3 (appendix
3), Table 9). The relative importance of each predictor variable
varied substantially by the specific aspect of survival studied and
modeling technique used.
The variable plots with observed 60-month survival (dichoto-
mous) proved to be very similar to the variable plots with pseudo
values at 60 months (continuous), except for the NNET model
(Figure 3).
*Cox regression was added as reference technique.
Discussion
In this study, we demonstrated that pseudo values as described
by Klein et al. [10,11] enable statistically appropriate analyses of
survival outcomes when used in in three variants of support vector
machines (SVM), neural networks (NNET), general linear models
(GLM), recursive partitioning (RPART) and logistic regression
(LR). We showed that pseudo values enabled us to apply these
techniques to predict survival in a case study of 1282 Dutch
patients with newly diagnosed HNSCC, and to compare the
performance of the resulting models.
Our analysis showed that conventional regression analysis
approaches (logistic regression and the generalized linear model)
outperformed the performance of relatively modern modeling
techniques. However, the SVM model with an optimal setting and
a linear kernel performed only slightly worse with respect to our
outcomes. The NNET model and the RPART model performed
relatively poorly.
We compared the performance of the alternative modeling
techniques in predicting three variants of survival outcome for our
case study. The first, admittedly rather simplistic, outcome
variable was based on the 60-month survival in terms of dead or
Table 5. Performance of models for the outcome ‘estimated survival time’.
Estimated survival time
Modeling technique RMSE bootstrap RMSE validated RMSE-apparent Optimism Optimism-corrected-RMSE
GLM 76.0 77.1 76.6 1.1 77.7
NNET 80.3 83.0 81.0 2.7 83.7
RPART 76.7 80.1 79.8 3.4 83.1
SVM LINEAR 77.4 78.7 77.9 1.3 79.2
SVM POLYNOMIAL 69.7 76.3 76.3 6.6 82.9
SVM RADIAL 69.7 76.4 76.8 6.7 83.4
doi:10.1371/journal.pone.0100234.t005
Figure 3. Variable importance of the models per outcome.
doi:10.1371/journal.pone.0100234.g003
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alive. This outcome may produce bias unless the censoring rate is
small (4% in our study). The other two outcome variables were
defined by means of pseudo values, which were derived from the
Kaplan Meier survival function.
A drawback of outcome definitions for 60 months is that they
only consider survival at a particular point in time rather than the
full survival curve. By contrast, the approach with the estimated
survival time is attractive, because it considers the full survival
Table 6. Mode of the parameter settings identified as optimal in bootstrap samples.
Outcome
Modeling technique Dead or alive at 60 months Pseudo values at 60 months Estimated survival time
LR 2 2 2
NNET size = 40 size = 30 size = 40
RPART cp = 0.01 cp = 0.01 cp = 0.01
SVM LINEAR cost = 0.5, gamma= 0.001 cost = 0.5, gamma= 0.001 cost = 0.5, gamma= 0.001
SVM POLYNOMIAL cost = 50, gamma= 0.05, degree = 3 cost = 25, gamma=0.05, degree = 3 cost = 50, gamma= 0.05, degree = 3
SVM RADIAL cost = 50, gamma= 0.05 cost = 0.5, gamma= 0.05 cost = 50, gamma= 0.05
doi:10.1371/journal.pone.0100234.t006
Table 7. Logistic regression model for the outcome ‘dead or alive at 60 months’.
Logistic regression
Variable Value B SE P-value OR 95% CI
Tumor location Glottic larynx (ref) 0.00 2 2 1.00 2
Lip 0.04 0.31 0.89 1.05 [0.5721.91]
Oral cavity 1.00 0.21 0.00 2.73 [1.8324.07]
Oropharynx 0.76 0.25 0.00 2.15 [1.3223.50]
Nasopharynx 20.09 0.41 0.82 0.91 [0.4122.03]
Hypopharynx 0.80 0.26 0.00 2.21 [1.3323.68]
Supraglottic larynx 0.39 0.22 0.07 1.48 [0.9722.26]
ACE27 Grade 0 (ref) 0.00 2 2 1.00 2
Grade 1 0.04 0.18 0.82 1.04 [0.7421.47]
Grade 2 0.36 0.19 0.06 1.43 [0.9922.08]
Grade 3 1.09 0.31 0.00 2.97 [1.6225.45]
T-class T1 (ref) 0.00 2 2 1.00 2
T2 0.67 0.17 0.00 1.95 [1.3822.74]
T3 0.90 0.21 0.00 2.47 [1.6223.76]
T4 1.30 0.21 0.00 3.68 [2.4425.55]
N-class N0 (ref) 0.00 2 2 1.00 2
N1 0.73 0.22 0.00 2.08 [1.3423.22]
N2 1.02 0.22 0.00 2.76 [1.8124.22]
N3 2.13 0.38 0.00 8.40 [3.98217.72]
M-class M0 (ref) 0.00 2 2 1.00 2
M1 1.65 0.85 0.05 5.23 [0.99227.63]
Prior malignancies No (ref) 0.00 2 2 1.00 2
Yes 1.04 0.24 0.00 2.83 [1.7824.50]
Gender Male (ref) 0.00 2 2 1.00 2
Female 20.05 0.17 0.77 0.95 [0.6821.33]
Age at diagnosis per decade 0.49 0.06 0.00 1.63 [1.4421.84]
Constant 24.79 0.44 0.00 0.01 2
B: Regression coefficient.
SE: Standard error regression coefficient.
OR: Odds ratio.
CI: Confidence interval.
doi:10.1371/journal.pone.0100234.t007
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curve. We consider the total expected survival time the most
relevant to inform patients about their prognosis and to support
decision making.
In our study, SVM models with a linear kernel and optimal
settings performed slightly worse than conventional regression
modeling. These findings are in line with other studies that used
support vector machines for analyzing survival [3–6]. On the other
hand, our findings also support the results of previous studies that
relied on Cox regression modeling to predict the five year
mortality and the overall mortality of newly diagnosed patients
with HNSCC [15–17].
None of the investigated models showed a very satisfactory
performance. This may possibly be explained by the low signal-to-
noise ratio in our data. In 1998, Ennis et al. discussed the
predictive performance of adaptive non-linear algorithms versus
conventional statistical techniques. Based on their quite negative
findings for the more modern algorithms, they postulated that
adaptive non-linear methods may be most useful in problems with
high signal-to-noise ratios, which sometimes occur in engineering
and physical science. Since the signal-to-noise ratio is often quite
low in medical prediction studies, they concluded that modern
methods may have less to offer [24].
A limitation of this study is that the results were based on a
single cohort of 1282 Dutch patients, diagnosed at a single center
[16]. We had to rely on bootstrap validation to estimate the
performance of alternative modeling techniques. On the other
hand, the number of events was more than sufficient to allow for
detailed statistical modeling with modern techniques for the
relatively small set of candidate predictors.
We showed that the use of pseudo values opens new possibilities
for analyzing survival problems with techniques other than
conventional regression techniques. The validity of the pseudo
value approach is supported by the concordance between Cox
regression modeling for censored survival time and Generalized
Estimating Equation modeling (GEE) using a log-minus-log link
function [11]. Therefore, this approach deserves a central role in
the ongoing search for improved prediction models for survival.
On the other hand, our results also show that it may be hard to
find modeling approaches that are superior to conventional
regression analysis in terms of performance, applicability and
simplicity.
Table 8. General linear model for the outcome ‘pseudo values at 60 months’.
General linear model
Variable Value B SE 95% CI P-value
Tumor location Glottic larynx (ref) 0.00 2 2 2
Lip 0.00 0.05 [20.1120.10] 0.93
Oral cavity 20.19 0.04 [20.26–20.11] 0.00
Oropharynx 20.14 0.05 [20.23–20.05] 0.00
Nasopharynx 20.06 0.08 [20.2120.09] 0.44
Hypopharynx 20.15 0.05 [20.25–20.06] 0.00
Supraglottic larynx 20.07 0.04 [20.1520.01] 0.08
ACE27 Grade 0 (ref) 0.00 2 2 2
Grade 1 0.00 0.03 [20.0620.06] 0.99
Grade 2 20.07 0.04 [20.1420.00] 0.06
Grade 3 20.19 0.05 [20.29–20.09] 0.00
T-class T1 (ref) 0.00 2 2 2
T2 20.13 0.03 [20.20–20.07] 0.00
T3 20.19 0.04 [20.27–20.11] 0.00
T4 20.27 0.04 [20.34–20.19] 0.00
N-class N0 (ref) 0.00 2 2 2
N1 20.16 0.04 [20.25–20.08] 0.00
N2 20.22 0.04 [20.29–20.14] 0.00
N3 20.37 0.05 [20.47–20.26] 0.00
M-class M0 (ref) 0.00 2 2 2
M1 20.27 0.11 [20.49–20.05] 0.02
Prior malignancies No (ref) 0.00 2 2 2
Yes 20.20 0.04 [20.28–20.12] 0.00
Gender Male (ref) 0.00 2 2 2
Female 0.01 0.03 [20.0520.07] 0.69
Age at diagnosis per decade 20.09 0.01 [20.11–20.07] 0.00
Constant 1.38 0.07 [1.2421.52] 0.00
B: Regression coefficient.
SE: Standard error regression coefficient.
CI: Confidence interval.
doi:10.1371/journal.pone.0100234.t008
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In conclusion, the use of pseudo values makes it readily possible
to analyze survival time with alternative modeling techniques, to
compare their performance and to search further for promising
alternative modeling techniques to analyze survival time. In our
case study on patients with newly diagnosed HNSCC, none of the
alternative modeling techniques provided better predictions for
survival than conventional regression modeling techniques. The
estimated importance of predictors depends on the specific aspect
of survival studied and the modeling technique used.
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